Guardant Health
GH
#1530
Rank
ยฃ10.15 B
Marketcap
ยฃ78.18
Share price
2.11%
Change (1 day)
174.05%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total assets

Total assets on the balance sheet as of September 2025 : ยฃ0.95 Billion

According to Guardant Health 's latest financial reports the company's total assets are ยฃ0.95 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Guardant Health - Total assets on balance sheet (from 2017 to 2025)

Total assets by year

Year Total assets Change
2024-12-31ยฃ1.18 B-15.57%
2023-12-31ยฃ1.40 B5.37%
2022-12-31ยฃ1.33 B-18.51%
2021-12-31ยฃ1.63 B-2.01%
2020-12-31ยฃ1.66 B127.06%
2019-12-31ยฃ0.73 B58.62%
2018-12-31ยฃ0.46 B82.37%
2017-12-31ยฃ0.25 B168.6%
2016-12-31ยฃ94.46 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Natera
NTRA
ยฃ1.36 B 42.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
ยฃ2.53 B 164.58%๐Ÿ‡บ๐Ÿ‡ธ USA